Paper Details

  1. Home
  2. Paper Details

WITHDRAWN: Eletriptan for acute migraine.

Author: McQuayH J, MooreR A, OldmanA D, SmithL A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Eletriptan (Relpax), a new type of migraine medication, will soon be available by prescription. There are currently five other similar medications available, and more are under development. With so many migraine treatments, evidence-based assessments are needed to compare their effectiveness and potential risks.
Paper Details　
Original Abstract of the Article :
Eletriptan (Relpax) is a new triptan soon to be made available by prescription for the treatment of acute migraine. Currently five triptans are available by prescription and more are under development. In light of the many drugs for treating acute migraine, there is a need for evidence-based assessm...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564092/

データ提供：米国国立医学図書館（NLM）

Eletriptan for Migraine: A Withdrawn Study

The world of neurology is constantly searching for effective treatments for conditions like migraine. This study examined the potential use of eletriptan, a medication for treating migraines, but it was ultimately withdrawn. The researchers were examining the efficacy and safety of this medication, like navigating a sandy path with careful steps.

While the study was withdrawn, it highlights the ongoing search for better migraine treatments. This study is a reminder that the development of new medications is a complex process, and sometimes, further research is needed before a treatment can be deemed safe and effective.

The Importance of Rigorous Research

The withdrawal of this study emphasizes the importance of rigorous research and the need for robust evidence before new medications are introduced. It is crucial to ensure that treatments are both effective and safe for patients.

Navigating Migraine Treatments

This research underscores the ongoing search for effective and safe treatments for migraine. It is important to consult with a healthcare professional to discuss the best treatment options for individual needs.

Dr.Camel's Conclusion

This withdrawn study reminds us that the journey to finding effective treatments for migraines is ongoing. It emphasizes the importance of rigorous research and the need for patience and perseverance in developing new therapies.

Date :
  1. Date Completed 2007-10-18
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

17636718

DOI: Digital Object Identifier

PMC6564092

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.